Agenda
- Jump to:
- At a Glance
- Day 1
- Day 2
- Print-friendly Format
Day 1 - Tuesday, June 16, 2020
8:30 |
Registration and Networking |
9:00 |
Opening Remarks from the Conference Chair |
9:10 |
Year in ReviewAnalysing Key Legal Developments and Determining if SPCs are Still Fit for Their Purpose |
10:30 |
Networking and Refreshments |
11:00 |
Handling SPCs Based on Secondary Medical Use Applications |
12:15 |
Lunch and Networking |
1:15 |
“Protection by a Basic Patent in Force”: Pending Referrals on Art. 3(a) Requirements |
2:30 |
Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents |
3:30 |
Networking and Refreshments |
4:00 |
National Patent Offices Speak on Overcoming Disparities of Protection in Europe |
5:15 |
Chair’s Summary: Key Takeaways From Day 1 |
5:30 |
Conference Adjourns |
Day 2 - Wednesday, June 17, 2020
9:00 |
Opening Remarks from the Conference Chair |
9:15 |
Keynote Presentation |
9:45 |
SPC Waiver (EU) 2019/933: Assessing the Impact of the Manufacturing Waiver One Year After Inception |
10:45 |
Networking and Refreshments |
11:15 |
Evaluating SPC eligibility in Non-Traditional and Novel Scenarios |
12:30 |
Lunch and Networking |
1:30 |
Seeking SPC Terms based on Third Party Marketing Authorisation (MA) |
2:30 |
Maximising Paediatric Exclusivity: Study of the Recent Swiss Experience |
3:00 |
Networking and Refreshments |
3:30 |
Securing and Extending Data Exclusivity While Staying Compliant with the Latest Transparency Rules and Regulations |
4:15 |
Chair’s Closing Remarks |
4:30 |
Conference Ends |
Day 1 - Tuesday, June 16, 2020
8:30 |
Registration and Networking |
9:00 |
Opening Remarks from the Conference Chair |
9:10 |
Year in ReviewAnalysing Key Legal Developments and Determining if SPCs are Still Fit for Their Purpose |
10:30 |
Networking and Refreshments |
11:00 |
Handling SPCs Based on Secondary Medical Use Applications |
12:15 |
Lunch and Networking |
1:15 |
“Protection by a Basic Patent in Force”: Pending Referrals on Art. 3(a) Requirements |
2:30 |
Analysing the Complications of Two-Part Teva Test and Its Implications for Compound Patents |
3:30 |
Networking and Refreshments |
4:00 |
National Patent Offices Speak on Overcoming Disparities of Protection in Europe |
5:15 |
Chair’s Summary: Key Takeaways From Day 1 |
5:30 |
Conference Adjourns |
Day 2 - Wednesday, June 17, 2020
9:00 |
Opening Remarks from the Conference Chair |
9:15 |
Keynote Presentation |
9:45 |
SPC Waiver (EU) 2019/933: Assessing the Impact of the Manufacturing Waiver One Year After Inception |
10:45 |
Networking and Refreshments |
11:15 |
Evaluating SPC eligibility in Non-Traditional and Novel Scenarios |
12:30 |
Lunch and Networking |
1:30 |
Seeking SPC Terms based on Third Party Marketing Authorisation (MA) |
2:30 |
Maximising Paediatric Exclusivity: Study of the Recent Swiss Experience |
3:00 |
Networking and Refreshments |
3:30 |
Securing and Extending Data Exclusivity While Staying Compliant with the Latest Transparency Rules and Regulations |
4:15 |
Chair’s Closing Remarks |
4:30 |
Conference Ends |